Read more
"Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes and gymnosperms. The chapters have been designed to thoroughly describe their isolation and screening process by using relevant technology to develop anticancer drugs; they also discuss the role of nutraceuticals and natural products from invertebrates in cancer treatment. This book presents a comprehensive approach of evolutionary diversities in natural products starting from the evolutionary mechanism, basic isolation, enumeration, and identification procedures to develop as anticancer agents. It also deals with some of the current challenges in prevention, and treatment of cancer against side effects of conventional drugs along with advanced therapeutic approaches by using natural products. This book is a valuable source for cancer researchers, oncologists, biotechnologists, pharmacologists and several members of biomedical field interested in understanding more about natural products with anticancer potential"--
List of contents
Preface1. Evolutionary mechanism for biosynthesis of diversemolecules2. Impact of ploidy changes on secondary metabolitesproductions in plants3. Effect of climate change on plant secondary metabolism:An ecological perspective4. Isolation and characterization of bioactive compounds fromnatural resources: Metabolomics and molecular approaches5. Single-celled bacteria as tool for cancer therapy6. Metabolic pathways for production of anticancercompounds in cyanobacteria7. Prophyletic origin of algae as potential repository ofanticancer compounds8. Metabolic versatility of fungi as a source for anticancercompounds9. Structural information of natural product metabolites inbryophytes10. Landscape of natural product diversity in land-plants assource for anticancer molecules11. Anticancer natural product from marine invertebrates12. Melatonin: A scientific journey from the discoveryin bovine pineal gland to a promising oncostatic agent:An evolutionary perspective13. Spice up your food for cancer prevention: Cancerchemo-prevention by natural compounds fromcommon dietary spices14. Significance of nutraceuticals in cancer therapy15. Common techniques and methods for screening of naturalproducts for developing of anticancer drugsIndex
About the author
Dr. Akhileshwar Kumar Srivastava works as a Research Associate (ICMR) in CSIR-Central Food Technological Research Institute, Mysore, India. In his eight years of research, he has published approximately 20 research articles and book chapters in international and national journals of repute. His research specialization is primarily in the area of pharmacognosy with genetics, metabolomics, bioinformatics, and molecular biology-associated targeting cancer diseases. In addition, he has studied at Augusta University (formerly, Georgia Regents University) in Augusta, GA, United States on a J-1 Exchange Scholar Visa and at Ben-Gurion University, Israel. He is also a life member fellow in Indian Science Congress and Agriculture, Nutrition and Health Academy, United Kingdom.Dr. Vinod Kumar Kannaujiya is an assistant professor in the Department of Botany, MMV, Banaras Hindu University, India. He earned his MSc and PhD degrees in Botany from the Centre of Advanced Study in Botany, Banaras Hindu University. He has been working on the ultraviolet stress response of cyanobacteria including value-added enzymes, proteins, pigments, and natural compounds. He has been awarded with prestigious fellowships from the Council of Scientific and Industrial Research, New Delhi, India. He has also been awarded the Dr. D.S. Kothari Post-Doctoral Fellowship from University Grant Commission, New Delhi, India, and he has received a UGC-Startup project grant from UGC, New Delhi, India. Dr. Kannaujiya is a life member fellow of the Indian Photobiology Society. Thus far, Dr. Kannaujiya has published over 49 original research papers, reviews, and book chapters.Dr. Rajesh Kumar Singh is currently working as a Research Associate in Banaras Hindu University. His research focus is pharmacognosy, reverse pharmacology, drug design and discovery, extraction & isolation of natural products, cell culture, and handling of different rodents. He has published several research articles in reputable journals over the course of his career. At present, he is involved in developing an Indian origin cell line and screening drugs of natural origin for the treatment of gallbladder cancer.Dr. Divya Singh is presently working as a scientist in Central Sericultural Research and Training Institute, Mysore, India. Her research specialization is primarily in genetics, proteomics, metabolomics, toxicology, bioinformatics, and molecular biological evaluation in various in vivo and in vitro plant models to elucidate the physiological changes and evaluate the DNA damage potency. She has published more
than 10 research articles including book chapters. In addition, she is also a life member fellow of Indian Science Congress.
